Explore 3 Stock Ideas & Industry Insights Download Free Report

Cambridge Cognition Holdings Plc

Company price
28.0 GBX 0.00(0%)
Last update at 2026-10-27T11:46:00Z
VOLUME
222
Market Cap
18.16M

Momentum Score

…

Cambridge Cognition Holdings Plc develops and markets digital solutions for the assessment of brain health in the United States, United Kingdom, the European Union, and internationally. The company offers digital cognitive assessments, including the CANTAB cognitive assessment battery, which measures cognitive function correlated to neural networks; a voice analysis platform, an automated speech assessment tool that provides real-time scoring for cognitive performance; and high frequency testing, which detects fluctuations in brain health with short tasks over regular timepoints. It also provides electronic questionnaires and scales (eCOA), which collect neurocognitive data in a data capture system; the automated quality assurance (AQUA) solution, which analyzes the audio during the administration of central nervous system (CNS) clinical scales to detect deviations in administration and scoring; and Clinpal, a decentralized clinical trials platform. Cambridge Cognition Holdings Plc was incorporated in 2012 and is headquartered in Cambridge, the United Kingdom.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
28.00
Low
29.00
High
52 Week Price Range
23.90
Low
45.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
28.00
Dividend Yield
-
Revenue TTM
9.05M
Revenue Per Share
0.22
Gross Profit TTM
7.25M
Debt / Equity
0.57
ROE
-68.57%
Net Debt
0.61M
ROCE
-27.23%
Diluted EPS TTM
-0.04

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -1.71M -3.46M -0.62M 0.25M -0.65M
Net income -1.78M -3.51M -0.41M 0.45M -0.44M
Selling general administrative 4.93M 6.14M 9.62M 7.83M 6.09M
Selling and marketing expenses 2.30M 2.98M - - -
Gross profit 8.39M 10.80M 9.32M 8.08M 5.42M
Reconciled depreciation 0.62M 0.67M 0.09M 0.15M 0.14M
Ebit -1.16M -3.29M -0.14M 0.26M -0.64M
Ebitda -0.54M -2.62M -0.04M 0.41M -0.50M
Depreciation and amortization 0.62M 0.67M 0.10M 0.15M 0.14M
Operating income -1.17M -3.31M -0.14M 0.26M -0.64M
Other operating expenses 11.51M 16.82M 12.75M 9.83M 7.38M
Interest expense 0.56M 0.17M 0.02M 0.01M 0.01M
Tax provision 0.08M 0.05M -0.21M -0.20M -0.21M
Interest income 0.02M 0.02M 0.01M 0.00M 0.00M
Net interest income -0.54M -0.15M -0.01M -0.01M -0.01M
Income tax expense 0.08M 0.05M -0.21M -0.20M -0.21M
Total revenue 10.34M 13.52M 12.61M 10.09M 6.74M
Total operating expenses 9.55M 14.10M 9.46M 7.82M 6.06M
Cost of revenue 1.96M 2.72M 3.29M 2.02M 1.32M
Total other income expense net -0.54M -0.15M -0.49M -0.01M -0.01M
Net income from continuing ops -1.78M -3.51M -0.41M 0.45M -0.44M
Net income applicable to common shares - - - 0.45M -0.44M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 13.03M 14.23M 15.11M 12.54M 6.26M
Intangible assets 3.33M 4.09M 0.94M 0.02M 0.03M
Other current assets 1.01M 1.21M - 5.13M 2.65M
Total liab 9.67M 12.95M 15.01M 11.91M 6.21M
Total stockholder equity 3.36M 1.28M 0.10M 0.63M 0.06M
Other current liab 6.65M 1.98M -0.02M -0.02M -0.10M
Common stock 0.42M 0.35M 0.31M 0.31M 0.31M
Capital stock 0.42M 0.35M 0.31M 0.31M 0.31M
Retained earnings -19.83M -19.78M -17.12M -16.88M -17.44M
Good will 3.45M 3.65M 0.48M 0.35M 0.35M
Cash 1.29M 3.22M 8.32M 6.81M 3.05M
Total current liabilities 8.76M 10.97M 15.01M 11.91M 6.21M
Current deferred revenue - 7.70M - - -
Net debt 0.61M -0.66M -8.30M -6.79M -2.95M
Short term debt 1.00M 0.58M 0.02M 0.02M 0.10M
Short long term debt 0.98M 0.57M - - -
Short long term debt total 1.91M 2.56M 0.02M 0.02M 0.10M
Other stockholder equity 17.57M 15.10M 16.90M 17.20M 17.18M
Property plant equipment - - - 0.05M 0.14M
Total current assets 4.34M 6.18M 13.45M 12.07M 5.75M
Net tangible assets - - - 0.26M -0.32M
Short term investments 0.01M 0.01M - - -
Net receivables 1.91M 1.55M 4.68M 5.13M 2.10M
Long term debt 0.91M 1.98M - - -
Inventory 0.13M 0.19M 0.22M 0.13M 0.05M
Accounts payable 0.85M 0.60M 15.01M 11.91M 6.21M
Accumulated other comprehensive income 5.21M 5.61M - - -
Common stock total equity - - - - 0.31M
Non currrent assets other 0.02M 0.02M 0.05M 0.05M -
Non current assets total 8.69M 8.05M 1.66M 0.47M 0.52M
Capital lease obligations 0.02M 0.02M 0.02M 0.02M 0.10M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments 0.05M -3.02M -0.18M -0.10M -0.04M
Change to liabilities - - - 5.78M 2.24M
Total cashflows from investing activities 0.05M -3.02M - -0.10M -0.04M
Net borrowings -0.55M 2.94M - -0.09M -0.11M
Total cash from financing activities 1.12M 2.88M -0.13M -0.10M 1.17M
Net income -1.71M -3.51M -0.62M 0.25M -0.65M
Change in cash -1.93M -5.10M 1.51M 3.76M 2.15M
Begin period cash flow 3.22M 8.32M 6.81M 3.05M 0.90M
End period cash flow 1.29M 3.22M 8.32M 6.81M 3.05M
Total cash from operating activities -3.08M -4.97M 1.67M 3.94M 1.01M
Issuance of capital stock 2.68M 0.06M 0.00M 0.00M 1.40M
Depreciation 0.62M 0.67M 0.09M 0.15M 0.14M
Other cashflows from investing activities 0.05M 0.02M - - 0.00M
Change to inventory 0.06M 0.03M -0.09M -0.07M 0.00M
Change to account receivables -0.21M 2.23M - -2.48M -1.01M
Other cashflows from financing activities -1.01M -0.11M -0.18M -0.10M -0.23M
Change to netincome - - - 0.12M 0.07M
Capital expenditures 0.00M 0.03M 0.19M 0.06M 0.04M
Change in working capital -2.82M -2.85M 1.84M 3.23M 1.24M
Stock based compensation 0.35M 0.16M 0.17M 0.11M 0.07M
Other non cash items 0.48M 0.56M 0.19M 0.01M 0.01M
Free cash flow -3.09M -5.00M 1.48M 3.89M 0.97M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
COG
Cambridge Cognition Holdings Plc
-
-%
28.00 - 12.84 2.01 7.68 2.10 100.23
CRW
Craneware Plc
2.00
0.18%
1088.00 29.63 11.26 2.36 1.84 2.89 9.61
OPT
Optima Health plc
-
-%
243.50 15.04 13.59 1.42 0.96 1.52 10.54
DXRX
Diaceutics PLC
1.50
0.75%
200.50 - 178.57 4.07 3.51 3.53 35.21
KOO
Kooth plc
-
-%
189.50 16.06 11.38 0.64 1.42 0.35 2.52

Profile*

Cambridge Cognition Holdings Plc

Cambridge Cognition Holdings Plc develops and markets digital solutions for the assessment of brain health in the United States, United Kingdom, the European Union, and internationally. The company offers digital cognitive assessments, including the CANTAB cognitive assessment battery, which measures cognitive function correlated to neural networks; a voice analysis platform, an automated speech assessment tool that provides real-time scoring for cognitive performance; and high frequency testing, which detects fluctuations in brain health with short tasks over regular timepoints. It also provides electronic questionnaires and scales (eCOA), which collect neurocognitive data in a data capture system; the automated quality assurance (AQUA) solution, which analyzes the audio during the administration of central nervous system (CNS) clinical scales to detect deviations in administration and scoring; and Clinpal, a decentralized clinical trials platform. Cambridge Cognition Holdings Plc was incorporated in 2012 and is headquartered in Cambridge, the United Kingdom.

Tunbridge Court, Cambridge, United Kingdom, CB25 9TU

44 1223 810 700

84

Name Title Year Born
Dr. Matthew Stork CEO & Director NA
Mr. John Hammond Co-Founder NA
Mr. Stephen Daniel Symonds CFO & Exec. Director 1975
Mr. Nick Taptiklis Head of Technology Strategy NA
Ms. Francesca Cormack Ph.D. Chief Scientist NA
Mr. Simon Merritt Marketing and Communications Director NA
Dr. Lisa Elizabeth Nolan Ph.D. VP Bus. Devel. 1962
Ms. Nicky Ackerley Global HR Director NA
Prof. Trevor Robbins Sr. Consultant NA
Prof. Barbara Sahakian FMedSci, FBPsS Sr. Consultant NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…